Condition

Antibody Mediated Rejection After Kidney Transplantation clinical trials and research

• 2Clinical trials
• 2Countries

All recruiting trials (2)

• BiTE therapy for chronic active antibody-mediated rejection after kidney transplant

  This study tests whether a BCMA×CD3 Bispecific T-cell Engager can help kidney transplant patients with chronic active antibody-mediated rejection.

  Recruiting Phase 4 West China Hospital · Chengdu, Sichuan · NCT07689578

• B cells in antibody-mediated kidney transplant rejection: their characteristics and what they react to.

  This project will test whether B cells taken from kidney transplant patients with suspected antibody-mediated rejection produce antibodies that react to donor HLA, other targets, or gut microbes.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris and 1 other locations · NCT07134491

Quick answers

How many Antibody Mediated Rejection After Kidney Transplantation clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in France (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →